ArticleFrontiers in pharmacology2025

Semaglutide promotes the proliferation and osteogenic differentiation of bone-derived mesenchymal stem cells through activation of the Wnt/LRP5/β-catenin signaling pathway.

Yawei Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.